Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious Diseases

BRISBANE, Calif.--(BUSINESS WIRE)-- #CRISPR--Mammoth Biosciences advances CRISPR platform, partnering with Vertex Pharmaceuticals to develop in vivo gene-editing therapies for serious diseases.

Click to view original post